WEI G,DE LEEUW E,PAZGIER M,et al.Through the lookingglass,mechanistic insights from enantiomeric human defensins[J].Journal of Biological Chemistry,2009,284(42):29180-29192.
[6]
BREUKINK E,DE KRUIJFF B.Lipid Ⅱ as a target for antibiotics[J].Nature Reviews Drug Discovery,2006,5(4):321-332.
[7]
余兴邦,郭锁链,乌翠兰,等.防御素研究进展[J].动物医学进展,2006,27(8):47-51.
[8]
ASHITANI J,NAKAZATO M,MUKAE H,et al.Recombinant granulocyte colony-stimulating factorinduces production of human neutrophil peptides in lung cancer patients with neutropenia[J].Regulatory Toxicology and Pharmacology,2000,95(1/2/3):87-92.
SELSTED M E,OUELLETTE A J.Mammalian defensins in the antimicrobial immune response[J].Nature Immunology,2005,6:551-557.
[12]
YANG D,BIRAGYN A,HOOVER D M,et al.Multiple roles of antimicrobial defensins,cathelicidins,and eosinophil-derived neurotoxin in host defense[J].Annual Review of Immunology,2004,22:181-215.
[13]
PORTER E.Distinct defensin profiles in Neisseria gonorrhoeae and chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions[J].Infection and Immunity,2005,73:4823-4833.
[14]
KOUGIAS P.Defensins and cathelicidins:neutrophil peptides with roles in inflammation,hyperlipidemia and atherosclerosis[J].Journal of Molecular Cell Biology,2005,9:3-10.
